PMID: 22344340Feb 22, 2012Paper

Low prevalence of gingival overgrowth associated to new imunossupressive protocols with cyclosporin

Brazilian Oral Research
Luiz Augusto WentzCassiano Kuchenbecker Rösing

Abstract

Gingival overgrowth (GO) is a frequent finding in patients treated with cyclosporine (CsA). This study investigated the prevalence and severity of GO in patients who received kidney transplant and CsA therapy, as well as associations with pharmacological and clinical factors. This cross-sectional study included 63 kidney transplant recipients who were treated with CsA in a university hospital. Demographic, pharmacological, and periodontal data were collected. The primary variable was GO. Independent sample t- and chi-square tests were used to compare means in groups with versus without GO. The response rate was 86.3%. Overall, 40% of patients had some degree of GO. Eleven individuals presented GO scores > 10%, and 5 individuals reached 30%. The mean GO percentage was low (6.79 ± 15.83). Patients that were concurrently under nifedipine treatment showed a non-significant trend toward a greater prevalence of GO. Mean CsA dosage and serum levels were 3.20 ± 0.94 mg/kg/d and 156.12 ± 162.75 ng/mL, respectively. There were no statistically significant differences between patients with versus without GO nor between the groups receiving nifedipine, no drug, or verapamil. The GO prevalence and severity rates were lower than those report...Continue Reading

References

Jan 1, 1992·Journal of Clinical Periodontology·R A Seymour, D J Jacobs
Oct 1, 1986·Oral Surgery, Oral Medicine, and Oral Pathology·T D DaleyC Day
Jul 1, 1985·Journal of Clinical Periodontology·R A SeymourD N Turnbull
Nov 1, 1967·Journal of Periodontology·H Löe
Nov 10, 1984·British Dental Journal·W R Tyldesley, E Rotter
May 1, 1983·Journal of Clinical Periodontology·E M Rateitschak-PlüssG Thiel
Jan 1, 1993·Journal of Clinical Periodontology·J M ThomasonN Rice
Apr 28, 2000·Journal of Clinical Periodontology·R A SeymourJ M Thomason
Nov 26, 2004·Journal of Periodontology·Anna Dongari-Bagtzoglou, UNKNOWN Research, Science and Therapy Committee, American Academy of Periodontology
Mar 16, 2005·Journal of Clinical Periodontology·J Mark ThomasonJanice S Ellis
Aug 18, 2005·Journal of Clinical Periodontology·M DrozdzikA Pawlik
Mar 5, 2008·Journal of Periodontology·Katja V GreenbergCaroline H Shiboski
Oct 1, 2004·Journal of Periodontology

❮ Previous
Next ❯

Citations

Dec 17, 2014·Periodontology 2000·Rui V OppermannCristiano Susin
Aug 9, 2016·Transplantation Proceedings·B Imko-WalczukB Rutkowski
Apr 5, 2015·European Journal of Orthodontics·Sotiria GizaniLisa Papagianoulis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.